Longeveron (LGVN) Assets Average (2023 - 2026)
Longeveron (LGVN) recorded quarterly Assets Average of $15.7 million in Q1 2026, up 21.9% quarter-over-quarter from $12.9 million in Q4 2025, and down 32.18% on a YoY basis from $23.2 million in Q1 2025.
Longeveron (LGVN) Assets Average (2023 - 2026) Analysis & Trends
Longeveron's Assets Average history runs 4 years deep, the most recent figure standing at $15.7 million for Q1 2026.
- In Q1 2026, Assets Average fell 32.18% year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $15.7 million (down 32.18% YoY), while the FY2025 annual figure was $17.9 million, down 4.83% from the prior year.
- Assets Average was $15.7 million for Q1 2026 at Longeveron, up from $12.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $27.7 million in Q4 2024 to a low of $10.9 million in Q1 2024.
- Historically, Assets Average has averaged $18.1 million across 4 years, with a median of $16.2 million in 2025.
- Biggest YoY gain for Assets Average was 134.01% in 2024; the steepest drop was 55.76% in 2024.
- A 4-year view of Assets Average shows it stood at $11.9 million in 2023, then soared by 134.01% to $27.7 million in 2024, then sank by 53.45% to $12.9 million in 2025, then gained by 21.9% to $15.7 million in 2026.
- The last three Assets Average figures came in at $15.7 million (Q1 2026), $12.9 million (Q4 2025), and $16.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | 15.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.74 Mn |
| Dec 31, 2025 | 12.91 Mn |
| Sep 30, 2025 | 16.15 Mn |
| Jun 30, 2025 | 18.80 Mn |
| Mar 31, 2025 | 23.20 Mn |
| Dec 31, 2024 | 27.73 Mn |
| Sep 30, 2024 | 24.65 Mn |
| Jun 30, 2024 | 14.55 Mn |
| Mar 31, 2024 | 10.89 Mn |
| Dec 31, 2023 | 11.85 Mn |
| Sep 30, 2023 | 14.36 Mn |
| Jun 30, 2023 | 19.45 Mn |
| Mar 31, 2023 | 24.61 Mn |